- Home
- AMTX vs TCRX Comparison
AMTX vs TCRX Comparison
Compare AMTX & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMTX
- TCRX
- Stock Information
- Founded
- AMTX 2005
- TCRX 2018
- Country
- AMTX United States
- TCRX United States
- Employees
- AMTX N/A
- TCRX N/A
- Industry
- AMTX Major Chemicals
- TCRX Biotechnology: Pharmaceutical Preparations
- Sector
- AMTX Industrials
- TCRX Health Care
- Exchange
- AMTX Nasdaq
- TCRX Nasdaq
- Market Cap
- AMTX 108.1M
- TCRX 98.5M
- IPO Year
- AMTX N/A
- TCRX 2021
- Fundamental
- Price
- AMTX $1.70
- TCRX $1.27
- Analyst Decision
- AMTX Strong Buy
- TCRX Strong Buy
- Analyst Count
- AMTX 4
- TCRX 6
- Target Price
- AMTX $14.56
- TCRX $9.83
- AVG Volume (30 Days)
- AMTX 810.0K
- TCRX 465.5K
- Earning Date
- AMTX 05-08-2025
- TCRX 03-05-2025
- Dividend Yield
- AMTX N/A
- TCRX N/A
- EPS Growth
- AMTX N/A
- TCRX N/A
- EPS
- AMTX N/A
- TCRX N/A
- Revenue
- AMTX $267,640,000.00
- TCRX $2,816,000.00
- Revenue This Year
- AMTX $39.00
- TCRX $32.21
- Revenue Next Year
- AMTX $58.39
- TCRX $118.35
- P/E Ratio
- AMTX N/A
- TCRX N/A
- Revenue Growth
- AMTX 43.34
- TCRX N/A
- 52 Week Low
- AMTX $1.50
- TCRX $1.26
- 52 Week High
- AMTX $5.63
- TCRX $9.69
- Technical
- Relative Strength Index (RSI)
- AMTX 39.51
- TCRX 27.99
- Support Level
- AMTX $1.81
- TCRX $1.44
- Resistance Level
- AMTX $2.03
- TCRX $1.76
- Average True Range (ATR)
- AMTX 0.16
- TCRX 0.18
- MACD
- AMTX -0.00
- TCRX -0.02
- Stochastic Oscillator
- AMTX 30.77
- TCRX 1.59
About AMTX Aemetis Inc. (DE)
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into advanced biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.